Soligenix poised to announce us commercialization plans of sgx301 in the treatment of cutaneous t-cell lymphoma

New york, new york--(newsfile corp. - january 25, 2021) - pcg digital: advancing health care innovation is a cornerstone of thorough public health policy. researching and developing new treatments for unmet medical needs has become increasingly important as the world continues to battle through the worst pandemic in our lifetime. while the news and focus of health innovation continues to be largely on covid-19, medical breakthroughs continue to progress across the board.soligenix, inc. (nasdaq: sngx)...
SNGX Ratings Summary
SNGX Quant Ranking